The Punjab government banned the sale and use of Coldrif syrup. The decision was taken following the incident in Madhya Pradesh. In this regard, orders have been issued by the Health Department.
The order said, “All retail sellers, distributors, registered medical practitioners, hospitals, and healthcare institutions in Punjab are prohibited from purchasing, selling, or using this product. If any stock of the syrup is found in the state, the information will be reported to the Food and Drug Administration.”
The Food and Drugs Administration (Drugs Wing), Punjab, in the interest of the people banned the Coldrif syrup. The order added, “Considering the seriousness of the matter, as the said product has been observed to be linked to the recent deaths of children in the Chhindwara District, Madhya Pradesh. The above-mentioned product is hereby completely prohibited for sale, distribution, and utilization in the state of Punjab with immediate effect in public interest.”
Details of the Drug
Drug Name: COLDRIF SYRUP (PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE SYRUP),
Batch Number: SR-13, Manufacturing Date: MAY/2025, Expiry Date: APR/2027, Manufacturer: Sresan Pharmaceutical Manufacturer, No: 787, Bangalore Highways, Sunguvarchatram, (Mathura), Kancheepuram District, 612106 of Tamil Nadu.
Deaths due to Coldrif Syrup
Let us tell you that the coldrif syrup has already been banned in multiple Indian states (including Madhya Pradesh, Tamil Nadu, Maharashtra, Kerala, and Telangana) due to confirmed contamination with high levels of diethylene glycol (DEG), a toxic industrial solvent. This contamination has been linked to the deaths of at least 11-14 children under age 5 from acute kidney failure in Madhya Pradesh and Rajasthan.